Controlling the Biological Behaviors of Polymer-Coated Upconverting Nanoparticles by Adjusting the Linker Length of Estrone Ligands

The estrone ligand is used for modifying nanoparticle surfaces to improve their targeting effect on cancer cell lines. However, to date, there is no common agreement on the ideal linker length to be used for the optimum targeting performance. In this study, we aimed to investigate the impact of poly(poly ethylene glycol methyl ether methacrylate) (PPEGMEMA) linker length on the cellular uptake behavior of polymer-coated upconverting nanoparticles (UCNPs). Different triblock terpolymers, poly(poly (ethylene glycol) methyl ether methacrylate)-block-polymethacrylic acid-block-polyethylene glycol methacrylate phosphate (PPEGMEMA(x)-b-PMAA(y)-b-PEGMP(3): x = 7, 15, 33, and 80; y = 16, 20, 18, and 18), were synthesized with different polymer linker chain lengths between the surface and the targeting ligand by reversible addition-fragmentation chain transfer polymerization. The estrone ligand was attached to the polymer via specific terminal conjugation. The cellular association of polymer-coated UCNPs with linker chain lengths was evaluated in MCF-7 cells by flow cytometry. Our results showed that the bioactivity of ligand modification is dependent on the length of the polymer linker. The shortest polymer PPEGMEMA(7)-b-PMAA(16)-b-PEGMP(3) with estrone at the end of the polymer chain was found to have the best cellular association behavior in the estrogen receptor (ER)alpha-positive expression cell line MCF-7. Additionally, the anticancer drug doxorubicin center dot HCl was encapsulated in the nanocarrier to evaluate the 2D and 3D cytotoxicity. The results showed that estrone modification could efficiently improve the cellular uptake in ER alpha-positive expression cell lines and in 3D spheroid models.

Automated summary

The bioactivity of ligand modification is dependent on the length of the polymer linker, with the shortest polymer PPEGMEMA(7)-b-PMAA(16)-b-PEGMP(3) found to have the best cellular association behavior in the ER alpha-positive expression cell line MCF-7. Additionally, estrone modification efficiently improves the cellular uptake in ER alpha-positive expression cell lines and in 3D spheroid models when encapsulated with the anticancer drug doxorubicin center dot HCl.